MEK Inhibitors for Pretreated, NRAS-Mutated Metastatic Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma: A multi-centre, retrospective study
Eur. J. Cancer 2022 May 01;166(xx)24-32, M Salzmann, J Pawlowski, C Loquai, DA Rafei-Shamsabadi, F Meiss, S Ugurel, D Schadendorf, F Meier, AH Enk, JC HasselFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.